U.S. pharma giant copyright scrapped two experimental weight loss drugs last 12 months—a as soon as-daily capsule, lotiglipron, on account of elevated liver enzymes as well as a two times-everyday tablet, danuglipron, due to solid Uncomfortable side effects—but CEO Albert Bourla has mentioned the company is determined to “Perform and get” d